{"symbol": "PGNX", "companyName": "Progenics Pharmaceuticals Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.progenics.com", "description": "Progenics Pharmaceuticals Inc is a biopharmaceutical company that develops innovative medicines and other technologies to identify, target and treat cancer. Its pipeline drugs include AZEDRA and 1095; 1404 and PyL; and imaging analysis tools.", "CEO": "Mark R. Baker", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}